Beta Adrenergic Antagonist for the Healing of Chronic DFU

Beta Adrenergic Antagonist for the Healing of Chronic DFU

Conditions: Chronic Diabetic Foot Ulcers; Diabetic Neuropathic Ulcers; Non Healing Wound
Interventions: Drug: Timolol; Drug: Non biologically active gel
Sponsors: VA Office of Research and Development; VA Northern California Health Care System
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 16, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments